NYSE:AGN - Allergan Stock Price, Forecast & News

Allergan trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGN."

Allergan announced a quarterly dividend on Friday, January 24th. Investors of record on Friday, February 14th will be paid a dividend of $0.74 per share on Friday, March 13th. This represents a $2.96 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date is Thursday, February 13th. View Allergan's Dividend History.

Allergan declared that its board has initiated a share buyback program on Tuesday, January 29th 2019, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4.1% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Allergan plc (NYSE:AGN) issued its quarterly earnings results on Tuesday, November, 5th. The company reported $4.25 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $4.25. The firm had revenue of $4.03 billion for the quarter, compared to analyst estimates of $3.88 billion. Allergan had a positive return on equity of 9.08% and a negative net margin of 58.50%. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.25 EPS. View Allergan's Earnings History.

Allergan is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Allergan.

Allergan updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of >$16.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.74. The company issued revenue guidance of $15.6-15.8 billion, compared to the consensus revenue estimate of $15.58 billion.

20 analysts have issued 1 year price objectives for Allergan's stock. Their forecasts range from $144.95 to $203.00. On average, they anticipate Allergan's share price to reach $176.63 in the next year. This suggests that the stock has a possible downside of 6.8%. View Analyst Price Targets for Allergan.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allergan in the last year. There are currently 17 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allergan.

Media headlines about AGN stock have been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Allergan earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Allergan.

Allergan saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 14,580,000 shares, an increase of 19.2% from the December 31st total of 12,230,000 shares. Based on an average daily volume of 2,220,000 shares, the short-interest ratio is presently 6.6 days. Currently, 4.5% of the company's shares are short sold. View Allergan's Current Options Chain.

Some companies that are related to Allergan include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allergan investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), NIC (EGOV), Transocean (RIG) and United Rentals (URI).

Allergan's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.24%), Strs Ohio (0.18%), New York State Teachers Retirement System (0.14%), Calamos Advisors LLC (0.11%), Metropolis Capital Ltd (0.06%) and Vertex One Asset Management Inc. (0.05%). Company insiders that own Allergan stock include Brent L Saunders, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado, Matthew M Walsh and William Meury. View Institutional Ownership Trends for Allergan.

AGN stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, Strs Ohio, United Services Automobile Association, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clark Capital Management Group Inc., Neville Rodie & Shaw Inc. and State of Alaska Department of Revenue. View Insider Buying and Selling for Allergan.

AGN stock was bought by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Calamos Advisors LLC, Metropolis Capital Ltd, Vertex One Asset Management Inc., Moon Capital Management LLC, Havens Advisors LLC, California Public Employees Retirement System and New York State Teachers Retirement System. Company insiders that have bought Allergan stock in the last two years include Brent L Saunders, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado and Matthew M Walsh. View Insider Buying and Selling for Allergan.

Shares of AGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AGN stock can currently be purchased for approximately $189.45.

Allergan has a market capitalization of $62.19 billion and generates $15.79 billion in revenue each year. The company earns $-5,096,400,000.00 in net income (profit) each year or $16.69 on an earnings per share basis. Allergan employs 16,900 workers across the globe.View Additional Information About Allergan.

The official website for Allergan is http://www.allergan.com/.

Allergan's mailing address is CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2, D17 E400. The company can be reached via phone at 862-261-7000 or via email at [email protected]